24/7 Market News Snapshot 24 September, 2025 – PepGen Inc. Common Stock (NASDAQ:PEPG)

September 24, 2025

DENVER, Colo., 24 September, 2025 (www.247marketnews.com) – (NASDAQ:PEPG) are discussed in this article.
PepGen Inc. has captured significant market attention, experiencing a remarkable surge in its stock price. The biotechnology company, which focuses on developing oligonucleotide therapies, saw its shares open at $1.95 before skyrocketing by 87.59% to a high of $3.658, reflecting a strong demand among investors. With a trading volume reaching approximately 8.36 million shares, investor enthusiasm suggests a revitalized confidence in the company and its potential growth, making PepGen a notable presence in the market.

In tandem with this bullish momentum, PepGen has announced an underwritten public offering of its common stock, which also includes pre-funded warrants for select investors. This strategic move is designed to finance ongoing research and development initiatives, particularly the critical FREEDOM-DM1 and FREEDOM2-DM1 clinical trials. Additionally, the net proceeds from the offering will be directed towards general working capital, reinforcing PepGen’s commitment to advancing therapies for serious neuromuscular and neurological disorders via its Enhanced Delivery Oligonucleotide (EDO) platform.

The securities will be issued under a recently effective registration statement on Form S-3. The preliminary prospectus supplement and accompanying prospectus will be accessible to interested parties through the Securities and Exchange Commission’s website, with distribution managed by the appointed joint book-running managers.

PepGen’s approach emphasizes innovative solutions developed from more than a decade of research, focusing on enhancing the targeted efficacy of oligonucleotide therapeutics through the use of cell-penetrating peptides. As the company progresses with its public offering, potential investors are advised to consider both the promising advances PepGen represents and the associated risks, all while anticipating further developments in their transformative journey within the biotechnology sector.

Related news for (PEPG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.